Northwest Pathology PLLC

Northwest Pathology PLLC was paid $17.79M by Medicaid between Jan 2018 and Dec 2024, across 83 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 67% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	21,794	$753K
2019	23,914	$747K
2020	77,996	$4.91M
2021	213,770	$6.77M
2022	111,894	$3.22M
2023	48,005	$866K
2024incomplete	16,510	$537K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	67%	167,671	136,036	$11.90M
88305	Level IV - Surgical pathology, gross and microscopic examination	11%	51,862	49,584	$1.96M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	4.9%	41,722	35,218	$880K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	2.9%	16,441	16,025	$509K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	2.8%	19,494	19,069	$506K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	2.1%	11,985	11,657	$368K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	2.1%	11,955	11,627	$366K
87481		<1%	4,303	2,616	$178K
88307		<1%	2,800	2,702	$151K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	4,056	3,910	$116K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	2,867	1,642	$108K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	1,717	1,407	$66K

71 more codes

87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	690	$54K
88304		<1%	5,714	$51K
88342		<1%	2,630	$49K
87511		<1%	1,629	$46K
88142		<1%	2,187	$41K
87634		<1%	744	$41K
80053	Comprehensive metabolic panel	<1%	5,419	$30K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	69	$28K
88141		<1%	1,815	$28K
88312		<1%	730	$25K
84443	Thyroid stimulating hormone (TSH)	<1%	3,201	$25K
80061	Lipid panel	<1%	3,380	$24K
87529		<1%	443	$23K
88341		<1%	926	$23K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	5,060	$22K
87625		<1%	703	$21K
36415	Collection of venous blood by venipuncture	<1%	10,553	$21K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	103,661	$19K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,091	$14K
83036	Hemoglobin; glycosylated (A1C)	<1%	3,310	$14K
82607		<1%	1,494	$12K
82746		<1%	1,144	$9K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	377	$8K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	144	$5K
82728		<1%	583	$4K
80048	Basic metabolic panel (calcium, ionized)	<1%	1,047	$4K
86803		<1%	200	$3K
87581		<1%	69	$2K
83550		<1%	554	$2K
85027		<1%	873	$2K
87486		<1%	69	$2K
83721		<1%	575	$2K
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	<1%	8,539	$2K
83540		<1%	600	$2K
88108		<1%	238	$2K
86769		<1%	42	$2K
88360		<1%	88	$2K
84436		<1%	437	$2K
87340		<1%	147	$1K
84479		<1%	392	$1K
84439		<1%	232	$1K
83970		<1%	57	$1K
85610		<1%	359	$1K
87070		<1%	132	$824.15
88302		<1%	149	$731.52
84481		<1%	45	$713.89
83735		<1%	163	$623.89
87653		<1%	44	$603.04
83880		<1%	55	$589.91
88189		<1%	13	$560.34
85046		<1%	188	$467.57
88112		<1%	53	$460.69
80076		<1%	42	$212.93
86702		<1%	15	$188.30
87563		<1%	20	$171.09
84100		<1%	52	$158.19
87186		<1%	35	$135.71
86701		<1%	15	$123.76
87077		<1%	28	$120.48
86140		<1%	28	$103.07
86706		<1%	13	$88.57
87088		<1%	50	$84.81
82977		<1%	16	$65.25
87205		<1%	15	$63.75
87086	Culture, bacterial; quantitative colony count, urine	<1%	206	$50.73
85652		<1%	19	$49.17
99072		<1%	2,138	$45.06
81001		<1%	16	$44.24
85007		<1%	18	$35.08
P9603	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled	<1%	43	$18.17
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	0%	184	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialWOLGAMOT, GREGORY (MEDICAL DIRECTOR)

Same official

Other billing entities under WOLGAMOT, GREGORY

Full network →

Provider	Location	Paid
Mattison Pathology, L.L.P.	Dallas, TX	$9.71M
Mattison Pathology, L.L.P.	Lubbock, TX	$558K
Northwest Pathology PLLC	Bellingham, WA	$77K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.